OPTIC-19
Research type
Research Study
Full title
Outcomes of Patients who survived Treatment on an Intensive Care unit for COVID-19 in England and Wales: a retrospective cohort study
IRAS ID
291887
Contact name
N/A CTRG
Contact email
Sponsor organisation
University of Oxford / Clinical Trials and Research Governance
Duration of Study in the UK
0 years, 10 months, 1 days
Research summary
Across England and Wales, over 10,000 patients have been treated for severe coronavirus disease 2019 (COVID-19) on an intensive care unit. Around 60% survived to leave hospital. We do not know how survivors’ severe COVID-19 infection, or the treatment they received on the intensive care unit, will affect their long-term health. Understanding what happens to these patients can help us make sure they receive suitable care from their GP and other NHS services after they leave hospital.
This study will follow up survivors for 1 year after discharge from hospital. We will use data collected by the Intensive Care National Audit and Research Centre (ICNARC) to identify patients who were treated on an ICU for COVID-19. We will then use NHS data to see whether these patients were readmitted to hospital and why. Information from the Office of National Statistics will allow us to know whether these patients died. By linking different sources of patient data, we will be able to estimate the health risks faced by survivors of severe COVID-19. We will compare these risks to patients treated on an ICU for other conditions.
REC name
South Central - Hampshire B Research Ethics Committee
REC reference
21/SC/0021
Date of REC Opinion
22 Feb 2021
REC opinion
Further Information Favourable Opinion